The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity
Open Access
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (18) , 5906-5917
Abstract
No abstract availableKeywords
Funding Information
- NCI (R01CA160981)
- VA Merit Award (I01CX000333)
This publication has 42 references indexed in Scilit:
- Oncogenic Potential of CYP24A1 in Lung AdenocarcinomaJournal of Thoracic Oncology, 2017
- Pregnenolone Functions in Centriole Cohesion during MitosisChemistry & Biology, 2014
- CYP1A1 Regulates Breast Cancer Proliferation and SurvivalMolecular Cancer Research, 2013
- 25-Hydroxyvitamin D-24-hydroxylase (CYP24A1): Its important role in the degradation of vitamin DArchives of Biochemistry and Biophysics, 2012
- The BATTLE to Personalize Lung Cancer Prevention through Reverse MigrationCancer Prevention Research, 2011
- The BATTLE Trial: Personalizing Therapy for Lung CancerCancer Discovery, 2011
- CYP24A1Is an Independent Prognostic Marker of Survival in Patients with Lung AdenocarcinomaClinical Cancer Research, 2011
- Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease2007
- Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancerAnnals of Oncology, 2004
- Profiling Breast Cancer by Array CGHBreast Cancer Research and Treatment, 2003